Astellas Pharma Inc. ( ALPMY) - Key Metrics
ALPMY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $362.38 | $80.10 | $49.55 | $42.41 |
| 2026Q4 | $361.50 | $32.36 | $115.85 | $106.65 |
| 2026Q3 | $324.65 | $57.02 | $41.93 | $33.38 |
| 2026Q2 | $297.83 | $45 | $132.35 | $124.62 |
| 2026Q1 | $281.72 | $38.11 | $30.54 | $23.41 |
ALPMY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 49.32% | 6.73 |
| 2026Q4 | 6.01% | 19.93 |
| 2026Q3 | 71.44% | 9.13 |
| 2026Q2 | 0.36% | 8.93 |
| 2026Q1 | 96.81% | 9.18 |
ALPMY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2027Q1 | 1.95% | 1.82% |
| 2026Q4 | 4.14% | 0.08% |
| 2026Q3 | 1.60% | 1.95% |
| 2026Q2 | 7.75% | 0.01% |
| 2026Q1 | 1.67% | 2.63% |
ALPMY
Price: $14.56
Dividend Yield: 3.05%
Forward Dividend Yield: 0.04%
Dividend Per Share: 0.01 USD
Earnings Per Share: 1.03 USD
P/E Ratio: 14.46
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 27.0 billion
Average Dividend Frequency: 3
Years Paying Dividends: 18
DGR3: -9.45%
DGR5: -3.53%
DGR10: 9.36%